SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " trial " 1,384 found 🔀 AI-powered Shuffle
100 mystery sounds under review for signs of extraterrestrial life
Over 11 years, citizen scientists collected billions of data signals for the SETI@home project.
Paramount+ Price Hike: It's your last chance to subscribe and save $30 or score a free trial
Here's how to lock in Paramount+'s current pricing before they raise their rates.
How “tribology” became a new industrial science
The deep study of friction and surfaces — so crucial to industrial manufacture — emerged from a mid-century engineering conference.
Earth's last 3 years were its hottest on record
For the first time, the three-year average global temperature was more than 1.5 degrees C above preindustrial temps.
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
Exceeded 10,000 patients treated to date with CARVYKTI® (ciltacabtagene autoleucel; cilta-cel)Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy manufacturing facility in the U.S.Profitability expected in 2026, driven by continued CARVYKTI® revenue growth and operating margin expansion Treated first patient with in vivo pipeline candidate in investigator-initiated trial Preclinical data from primates provided early validat
Industrial parks: The County’s massive business park offers ‘promising’ outlook
Loring, which is on a former Air Force base, is Maine’s largest business park by size, with 8,700 acres, and is a key piece of Aroostook County’s place in the region’s larger economy.
Schools to receive £55,000 mental health trial in Cherwell
Oxfordshire County Council will fund the scheme across the Cherwell District following a new report.
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026; Phase 3 initiation on track for Q3 2026 12-week data from Phase 1 trial of MBX 4291, a dual GLP-1/GIP co-agonist prodrug with potential for once-monthly dosing and improved tolerability for obesity, anticipated in Q4 2026 Nomination of two additional obesity candidates expected in 2026: an amycretin prodrug and a GLP-1/GIP/GCGR triple agonist,
Advancing Claude in healthcare and the life sciences
Introducing Claude for Healthcare with HIPAA-ready infrastructure, plus expanded Life Sciences tools for clinical trials and regulatory submissions. New connectors to CMS, Medidata, and ClinicalTrials.gov.
Advancing Claude in healthcare and the life sciences
Introducing Claude for Healthcare with HIPAA-ready infrastructure, plus expanded Life Sciences tools for clinical trials and regulatory submissions. New connectors to CMS, Medidata, and ClinicalTrials.gov.
L3Harris announces $845 million majority sale of Space Propulsion and Power Systems business
The deal with AE Industrial Partners is expected to close in the second half of 2026. L3Harris will retain full control over the RS-25 engine.
Superconductors, an opportunity for science and society
Superconductive technologies have long been central to particle physics, but they have also repeatedly moved beyond the laboratory, most notably with the emergence of magnetic resonance imaging scanners (MRI), demonstrating how breakthroughs in fundamental research can benefit society. Today, as global energy, climate and healthcare pressures grow, the conversation is shifting from “What can science give to society?” to “How can science and industry jointly develop technologies that benefit society while advancing research?” The event “Catalysing Impact – Superconductivity for Global Challenges” held at CERN in December was aimed precisely at answering this question. The workshop brought together leading researchers, industry representatives, investors and policymakers to explore how collaboration on superconducting technologies can advance particle physics while addressing some of the world’s most pressing societal challenges. The event sought to bridge fundamental research with real-world deployment and to accelerate collaborative pathways. Across keynotes, panels and round tables, participants examined both the current technological landscape and the opportunities ahead. Introducing the discussions, Frédérick Bordry, Chief Technology Officer of the Gauss Fusion company and former CERN Director for Accelerator and Technology, noted that “Superconductivity has become the silent engine of discovery science.” While the research community needs more capable and more resilient superconductors for the next generation of experiments, they also have significant potential for societal applications. Beyond their role in collider magnets, high-temperature superconductors (HTS) now promise lossless power transmission, compact fusion magnets, efficient renewable systems and new capabilities in healthcare, transport, computing and quantum technologies - all aligned with SDG-17’s emphasis on partnership-driven innovation. Participants also stressed that major hurdles remain. Global competition is accelerating, and Europe must act quickly to secure technological and economic leadership. Doing so will require coordinated investment and supportive policies, including stronger risk capital investment and mechanisms to bridge the gap between laboratory innovation and industrial deployment. The summit set in motion several concrete follow-up priorities, including aligning R&D roadmaps with societal goals and the UN Sustainable Development Goals; making it easier for public–private consortia to build demonstrators that serve both industry and research needs; and advancing investment pathways that better connect research institutions, governments and the private sector. A series of interviews of key participants is available here: Frédérick Bordry & Milena Roveda Mike Lamont Francesca Ferrazza Peter Schroth Ziad Melhem Pietro Corsaro
Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards
MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today announced it has been named a finalist for two prestigious SCOPE Awards: the Participant Engagement Award and the Site Innovation Award. This marks the first time that a single company has been named a finalist for two SCOPE Award categories in the same year. Driving Engagement Through Community Pharmacies Science 37 was recognized for the Participant Engagement Award
Startups to watch: Baton Rouge’s entrepreneurial surge
Put researchers, incubators and investors in the same ecosystem, and you get a region where innovation can thrive. That momentum is showing up in the number of Capital Region startups now drawing attention far beyond Louisiana. CodeGig CodeGig is a Baton Rouge software firm that leverages artificial intelligence and machine learning to help industrial companies […]
Advanced alien civilizations could be communicating 'like fireflies' in plain sight, researchers suggest
A new paper posits that advanced alien civilizations may communicate through subtle flashes, like fireflies do on Earth. The thought experiment suggests that we need to avoid human biases in our search for extraterrestrial life.
Nvidia Vera Rubin, Dow tops 49K, business optimism: 3 Things
Nvidia (NVDA) CEO Jensen Huang unveiled a variety of new projects and innovations at his keynote speech at CES 2026 on Monday, including the chipmaker's Vera Rubin AI platform. US stock futures (ES=F, NQ=F, YM=F) are mixed in Tuesday's premarket trading after the Dow Jones Industrial Average (^DJI) reached a new record high above 49,000 yesterday. A majority of small and medium business owners appear cautiously optimistic for 2026, according to a new study from Bank of America. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.
L3Harris sells 60% stake in space propulsion business for $845 million
L3Harris Technologies said on Monday it will sell an about 60% stake in its space propulsion and power systems business to private equity firm AE Industrial Partners for $845 million, including debt.
First US at-home depression kit on its way after trial shows benefits in weeks
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major depressive disorder (MDD).
Lee: Junk science in courts hurts everyone
Junk science admitted during trial continues to undermine our judicial system.
Everyday chemicals are quietly damaging beneficial gut bacteria
A large study has revealed that dozens of widely used chemicals can damage beneficial gut bacteria. Many of these substances, found in pesticides and everyday industrial products, were never thought to affect living organisms at all. When gut bacteria are stressed by these chemicals, some may also become resistant to antibiotics. The research raises new questions about how chemical exposure could be influencing human health behind the scenes.
Brother went from business partner to murder suspect accused of killing 4 and torching 2 houses
Paul Caneiro's long-awaited quadruple murder trial is set to open Monday in New Jersey.
Weekend reads: Evaluating the benefits of open science, a misconduct investigation in Korea, and what we lose in outsourcing reviews to AI
Happy 2026! We’re excited to bring you the first Weekend Reads of the new year. The week at Retraction Watch featured: The BMJ retracts clinical trial for ‘severe’ discrepancies in rand…
Man accused of placing pipe bombs near GOP and Democratic headquarters in Washington to remain in jail pending trial
Brian Cole Jr. allegedly placed explosives outside the Democratic and Republican National Committee buildings on January 5, 2021.
George Mason ‘Stepping up’ to challenges of A10 play
Despite roster changes and injuries, the Patriots have met every test and trial head-on this season.
BioAtla and GATC Health to advance Oz-V in Phase III trial
BioAtla and GATC Health have entered into a $40m SPV transaction to advance Oz-V into a Phase III trial for 2L+ OPSCC.
Should the NHS really use magic mushrooms to treat mental health?
Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 - with surprising results
A One Health trial design to accelerate Lassa fever vaccines
Nature Medicine - We propose an interdisciplinary framework to address the considerable challenges that are restricting the development of vaccines for zoonotic diseases with epidemic potential.
This 100-year-old teaching method is beating modern preschools
A first-of-its-kind national trial shows that public Montessori preschool students enter kindergarten with stronger reading, memory, and executive function skills than their peers. These gains don’t fade — they grow over time, bucking a long-standing trend in early education research. Even better, Montessori programs cost about $13,000 less per child than traditional preschool. The results suggest a powerful, affordable model hiding in plain sight.
Alleged DC pipe bomber to appear at detention hearing as his attorneys argue he should be released from jail
Ahead of a detention hearing Tuesday for the man accused of placing two pipe bombs near the Republican and Democratic National Committee buildings in 2021, defense attorneys argue their client should be released from jail while awaiting trial, in part because the bombs never detonated.
Why your vitamin D supplements might not be working
A new randomized trial from Vanderbilt-Ingram Cancer Center reveals that magnesium may be the missing key to keeping vitamin D levels in balance. The study found that magnesium raised vitamin D in people who were deficient while dialing it down in those with overly high levels—suggesting a powerful regulating effect. This could help explain why vitamin D supplements don’t work the same way for everyone and why past studies linking vitamin D to cancer and heart disease have produced mixed results.
Trump says pardon for Netanyahu is 'on its way,' but Herzog denies claim
President Trump said Israeli President Isaac Herzog informed him that he plans to pardon Benjamin Netanyahu amid a long-running corruption trial.
Musk sounds alarm on silver as China restricts exports needed for critical industrial processes
Elon Musk warned that China's new silver export restrictions could hurt industries using the metal as an input with the precious metal's prices hit record highs.
Protecting the ‘Holiday heart:’ What to know about heart health during the holiday season, new smart watch technologies
Dr. Nassir Marrouche is director of the Heart and Vascular Institute at Tulane University with a subspecialty in electrophysiology. He treats atrial fibrillation, heart arrhythmia, irregular heartbeats, sudden cardiac death
Aren't Oregon's farmers, ranchers and stewards 'Oregon business'?
Both Gov. Kotek's Oregon Prosperity Roadmap and the Oregon Business Plan have elicited fanfare and criticism. As the director of an organization whose members’ livelihoods are tied to businesses inside and outside our urban growth boundaries, I am concerned that these roadmaps emphasize industrial and tech development, calling to pave over our farms, forests, and watersheds.
I left my dream job as a trial attorney and pivoted into AI at age 40. It showed me the power of leaving my comfort zone.
Aurora Bryant, 40, stopped practicing law to work for Relativity, an AI-powered legal data intelligence company. She said it paid off.
Mental health evaluation for Apalachee High School shooting suspect due in February
The mental health evaluation for Apalachee High School shooting suspect Colt Gray is expected to be finished in February, potentially deciding his trial eligibility.
The best everyday health advice we learned from science in 2025
We certainly saw some major health-related breakthroughs in 2025, including a universal cancer vaccine and human trials for the world's first treatment to reverse spinal cord injuries. But the year was also filled with smaller findings that can still have a big impact on your day-to-day health.
This popular painkiller may do more harm than good
Tramadol, a popular opioid often seen as a “safer” painkiller, may not live up to its reputation. A large analysis of clinical trials found that while it does reduce chronic pain, the relief is modest—so small that many patients likely wouldn’t notice much real-world benefit. At the same time, tramadol was linked to a significantly higher risk of serious side effects, especially heart-related problems like chest pain and heart failure, along with common issues such as nausea, dizziness, and sleepiness.
This tiny peptide could help stop brain damage after injury
A four–amino acid peptide called CAQK has shown powerful brain-protective effects in animal models of traumatic brain injury. Delivered through a standard IV, it zeroes in on injured brain tissue, calming inflammation and reducing cell death while improving recovery. The peptide worked in both mice and pigs, whose brains are closer to humans in structure. Researchers are now preparing to move toward early human clinical trials.
New trial at UC Davis Health shows promising results for rare liver disease
A new monoclonal antibody for a rare liver disease, primary sclerosing cholangitis, showed promising efficacy in a recent multicenter study led by UC Davis Health.
Iryna’s Law aims to improve public safety — but it may deepen jail and health care strains
North Carolina sheriffs say stricter pretrial release rules could test capacity, staffing and county budgets.
December 22, 2025: Rural Health Symposium Opens Registration, Announces Call for Abstracts
The Duke University School of Nursing will convene healthcare professionals, educators, researchers, community leaders, and policymakers for a 1-day symposium dedicated to reducing rural health disparities across North Carolina through […]
Inside the Dubai chocolate boom and the factories racing to keep up
We visited the creator of Dubai chocolate and its first industrial operation and traced how the supply chain is racing to meet soaring demand.
Streeting says NHS ‘coping’ during resident doctors’ strike but faces difficult recovery over Christmas
Five-day industrial action is due to end tomorrow, and health secretary says talks will resume in new year
Science news this week: Japan laser weapon trial, comet 3I/ATLAS bids farewell, and AI solves 'impossible' math problems
Dec. 20, 2025: Our weekly roundup of the latest science in the news, as well as a few fascinating articles to keep you entertained over the weekend.
Paxtons agree to unseal records in divorce case after media challenge
A group of eight media organizations had requested records in the divorce case between Paxton, who is running for U.S. Senate, and his wife be made public.
2 defendants in 'Buffalo Billion' case agree to plea deal to avoid retrial
Documents say Steven Aiello and Joseph Gerardi have pleaded guilty to one count of conspiracy to commit wire fraud.
PayPal plans to launch bank serving small businesses around the US
PayPal files with Utah and the FDIC to launch PayPal Bank, an industrial loan company offering small business lending and FDIC-insured savings accounts.
Efficacy of a digital health application for weight management in people with obesity: 6-months results from a randomized controlled trial
International Journal of Obesity - Efficacy of a digital health application for weight management in people with obesity: 6-months results from a randomized controlled trial
Dental Stem Cells Show Promise Beyond Oral Health
Multipotent dental stem cells can give rise to various cell types and show potential for treating injuries, diabetes, and heart disease in early clinical trials.
The Search for Life Tops NASA's Science Goals for the First Human Mars Mission
A new report identifies searching for life as the top science priority for humanity's first landing on Mars, ranking it above understanding water cycles, mapping geology, or even studying how the Martian environment affects astronaut health. The report outlines four possible exploration campaigns, with the highest ranked approach calling for missions totalling 330 sols at a single scientifically rich site where crews could investigate everything from ancient lava flows to active dust storms. By placing the search for extraterrestrial life at the centre of human Mars exploration, the report reimagines the first crewed mission not just as a milestone for spaceflight but as humanity's best chance to answer whether we're alone in the universe.
Guardant Health and Trial Library to expand access to US cancer trials
Trial Library’s platform is said to provide access to trials within community-based settings, spanning over 320 clinics.
AI Bubble Or Business Revolution? Essential Business Insights
Most AI companies will fail, yet the industry will transform business. The trial and error economy drives today's AI revolution alongside significant risks.
Michael Jordan prevails in settlement of antitrust lawsuit against NASCAR
Jordan's 23XI Racing team, along with Front Row Motorsports, reached a deal with NASCAR on the ninth day of their federal trial.
Lockheed Martin moving forward with $51M expansion project in Owego
Tioga County Industrial Development Agency says construction is slated to begin before the new year.
Worker Injured After Becoming Trapped In Machine At South Windsor Business
Authorities said the injured employee was found on top of industrial equipment and needed to be rescued.
Netflix director takes the stand, recounts 5-week scramble to save sci-fi project at heart of his $11 million fraud trial
Carl Rinsch, the director behind "Ronin 47" with Keanu Reeves, took the stand in his own defense. He faces up to 90 years in prison if convicted.
Certified industrial development land is dedicated at Holmen business parks
New industrial sites are becoming available in Holmen. LADCO hosted a ribbon-cutting ceremony Tuesday, to dedicate property that is ready for development at two business parks north of downtown Holmen. The sites have been certified by state officials as ready for new construction. Vicki Markussen, the executive director of LADCO, says the two new development […]
City looks to boost business with industrial revenue bonds
CASPER, Wyo. — The City of Casper may move forward with plans to use industrial revenue bonds as an industry-boosting strategy for business recruitment
Clarksville Industrial Association: Where business leaders connect and collaborate
The Clarksville Industrial Association (CIA) is a cornerstone of business engagement in Montgomery County, bringing together more than 100 leaders each quarter.
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5% reduction in total body fat (3.5 lbs; p=0.07), and a 3.2% increase in lean mass (4.0 lbs; p=0.01), with no statistically significant changes in the placebo group Sustained and robust suppression of serum Activin E supports expectations for continued improvements in body composition, further fat loss, and p
New Medicare trial may boost digital care
Traditional Medicare payment policies make digital health adoption difficult.
Humans are built for nature not modern life
Human biology evolved for a world of movement, nature, and short bursts of stress—not the constant pressure of modern life. Industrial environments overstimulate our stress systems and erode both health and reproduction. Evidence ranging from global fertility declines to chronic inflammatory diseases shows the toll of this mismatch. Researchers say cultural and environmental redesign, especially nature-focused planning, is essential.
Netanyahu says he won’t quit politics in exchange for pardon in corruption trial
At joint press conference with German chancellor, premier firmly rejects idea of walking away from political life, says voters will decide 'my future'
Weekend reads: ‘The fall of a prolific science journal’; Clinical trials by ‘super-retractors’; ‘How to Study Things That May Not Exist’
Giving Tuesday was this week, and, like many organizations, we asked for your support. The work we do is funded in part by your donations. If you value our work in rooting out scientific fraud and …
'Get all that Hermes stuff now': Netflix director accused of $11 million fraud rushed to buy luxury goods, texts show
Netflix director Carl Rinsch purchased a Swedish mattress that a trial witness said comes with a "bed doctor" who visits your house to massage it.
A look back at the top 10 Capital Region business stories of 2025
From political shake-ups to billion-dollar industrial bets, the Capital Region’s biggest business headlines this year delivered plenty of suspense, as Business Report highlights in its latest issue. Baton Rouge’s arena dreams faced a plot twist when Oak View Group—the partner LSU wants for the job—got pulled into a federal indictment tied to bid-rigging allegations in […]
New Study Challenges Global Health Advice: Reducing Sweetness Won’t Curb Cravings
A large clinical trial found that changing how much sweetness people consume does not affect their preference for sweet tastes or their metabolic health. Adjusting how much sweetness people consume appears to have no effect on how much they enjoy sweet foods, according to a new clinical trial.
ARCH-backed Paradigm snaps up Flatiron’s clinical research business
The Flatiron acquisition complements a $78m funding round, which will aid Paradigm's efforts to integrate clinical trials into routine care.
Louisiana’s secret business negotiations need to stop, critics say
Louisiana leaders have touted new industrial projects that promise to create thousands of jobs, but critics say these secret business negotiations need to stop.
Lessons from the Past: Responsible Science and Astrobiology
In a recent paper, a team of SETI and astrobiology specialists examines four controversial claims about the existence of extraterrestrial life. From these, they present recommendations for scientists and science communicators when addressing future claims of discovery.
Second padel recreational sports complex planned in Milwaukee
Epic Padel, an Arlington, Virginia-based indoor sports complex operator, is planning its first Wisconsin location in a new industrial building on
ASRock puts extra DDR4 slots to its DDR5 H610M COMBO motherboard
ASRock H610M COMBO brings DDR4/DDR5 flexibility to business desktops ASRock has introduced the H610M COMBO, a Micro ATX motherboard for Intel LGA1700 that targets business and enterprise desktops rather than gaming builds. The board is based on Intel’s H610 chipset and a simple 3+1 power phase design, aimed at office PCs, industrial systems, and OEM […]
Paradigm Health raises $78M, buys Flatiron unit
A growing group of solutions is streamlining clinical trials and drug approvals.
Paradigm Health, seeking to use AI to enroll clinical trials, partners with Roche
Paradigm Health, which is seeking to use AI to enroll clinical trials, has raised more funds and is acquiring a business from Flatiron Health.
Construction underway at Hazzard Business Park
Construction is underway in Spokane’s Chief Garry Park neighborhood on a $1.5 million industrial park dubbed Hazzard Business Park, located just southwest of the Trent Avenue and Freya Street intersection, says owner and developer Luke Shuman.
Renowned astronomers push to protect Chile’s cherished night sky from an industrial project
Chile’s Atacama Desert is one of the darkest spots on earth, a crown jewel for astronomers who flock from around the world to study the origins of the universe in this inhospitable desert along the Pacific coast.
The HPV vaccine is safe and cuts cervical cancer risk by 80%, 2 large reviews find
Hundreds of studies, including gold-standard clinical trials, challenge Health Secretary Robert F. Kennedy Jr.’s claim that the cancer vaccine is harmful.
An extra solar system planet once orbited next to Earth — and it may be the reason we have a moon
Earth may have a moon today because a nearby neighbor once crashed into us, a new analysis of Apollo samples and terrestrial rocks reveals.
Netanyahu's unusual pardon request sets up political test
Benjamin Netanyahu's request for a pardon to "promote reconciliation" in Israel has sparked huge debate, as the prime minister's long-running corruption trial continues to divide Israeli society.
Bar, commercial and industrial: See 21 latest business, apartment, land sales ($2K to $1.2M)
See a list of property sales in Onondaga County other than residential homes.
Science 37 Honored for Site Innovation in the 2025 Clinical Trials Arena Excellence Awards
Science 37 is the Winner of Research and Development Award in the Site Innovation category in the 2025 Clinical Trials Arena Excellence Awards
Luigi Mangione set to return to court for pretrial hearing in killing of health care CEO
The 27-year-old accused killer’s lawyers have asked the court to allow him to remain unshackled during the hearing, which could last at least a week.
The Sunshine Hormone’s Second Act: Why Science is Rethinking Vitamin D
New research reclassifies Vitamin D from a bone-health nutrient to a systemic steroid hormone, challenging public health guidelines. This deep dive explores the conflict between clinical trials and molecular biology, the potential for cancer and autoimmune prevention, and the future of personalized supplementation based on genetic metabolism.